Gilead Targets Lupin Over Generic Ranexa
Biopharmaceutical company Gilead Sciences Inc. has fired off a patent infringement suit against Lupin Ltd., seeking to block the Indian generic-drug maker from offering a copycat version of chronic chest pain...To view the full article, register now.
Already a subscriber? Click here to view full article